5,172 reports of this reaction
3.2% of all ESTRADIOL reports
#3 most reported adverse reaction
PRODUCT ADHESION ISSUE is the #3 most commonly reported adverse reaction for ESTRADIOL, manufactured by Allergan, Inc.. There are 5,172 FDA adverse event reports linking ESTRADIOL to PRODUCT ADHESION ISSUE. This represents approximately 3.2% of all 159,657 adverse event reports for this drug.
Patients taking ESTRADIOL who experience product adhesion issue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT ADHESION ISSUE is moderately reported among ESTRADIOL users, representing a notable but not dominant share of adverse events.
In addition to product adhesion issue, the following adverse reactions have been reported for ESTRADIOL:
The following drugs have also been linked to product adhesion issue in FDA adverse event reports:
PRODUCT ADHESION ISSUE has been reported as an adverse event in 5,172 FDA reports for ESTRADIOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT ADHESION ISSUE accounts for approximately 3.2% of all adverse event reports for ESTRADIOL, making it one of the most commonly reported side effect.
If you experience product adhesion issue while taking ESTRADIOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.